Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy

被引:0
|
作者
T. Komori
N. Arai
M. Oda
H. Nakayama
H. Mori
S. Yagishita
T. Takahashi
N. Amano
S. Murayama
S. Murakami
N. Shibata
M. Kobayashi
S. Sasaki
M. Iwata
机构
[1] Department of Clinical Neuropathology,
[2] Tokyo Metropolitan Institute for Neuroscience,undefined
[3] 2-6 Musashidai,undefined
[4] Fuchu City,undefined
[5] Tokyo 183-8526,undefined
[6] Japan e-mail: komori@tmin.ac.jp,undefined
[7] Tel.: +81-423-25-3881,undefined
[8] Fax: +81-423-21-8678,undefined
[9] Department of Laboratory Medicine and Psychiatry,undefined
[10] Tokyo Metropolitan Neurological Hospital,undefined
[11] Tokyo,undefined
[12] Japan,undefined
[13] Department of Pathology,undefined
[14] Kanagawa Rehabilitation Center,undefined
[15] Yokohama,undefined
[16] Japan,undefined
[17] Department of Neuropsychiatry,undefined
[18] Neurology and Pathology,undefined
[19] Faculty of Medicine,undefined
[20] University of Tokyo,undefined
[21] Tokyo,undefined
[22] Japan,undefined
[23] Department of Pathology and Neurology,undefined
[24] Tokyo Women’s Medical College,undefined
[25] Tokyo,undefined
[26] Japan,undefined
来源
Acta Neuropathologica | 1998年 / 96卷
关键词
Key words Corticobasal degeneration; Progressive; supranuclear palsy; Astrocytic plaques; Tufts of; abnormal fibers; Gallyas-Braak silver staining;
D O I
暂无
中图分类号
学科分类号
摘要
Corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) are characterized by their unique clinical features and neuronal pathology. Although astrocytic plaques and tufts of abnormal fibers have been suggested to be specific histopathologic markers, recent studies have revealed significant clinicopathologic overlap between CBD and PSP. Based on the distinctive camera lucida profile of astrocytic inclusions on Gallyas-Braak silver staining, we found that astrocytic plaques and tufts of abnormal fibers did not coexist in the same patient among 30 cases of clinically diagnosed CBD, PSP and atypical Parkinson’s disease. Using Tau immunohistochemistry it was difficult to verify the absence of tufts of abnormal fibers. A morphometric analysis revealed that the two groups classified by the presence or absence of astrocytic plaques and tufts of abnormal fibers exhibited significant differences in the density of ballooned neurons and neurofibrillary tangles and degeneration of the subcortical nuclei. Assessment using the NINDS neuropathologic criteria revealed that the cases with astrocytic plaques and tufts of abnormal fibers closely correspond to CBD and typical PSP, respectively. In addition, the cases lacking either of these two astrocytic inclusions had atypical PSP according to the NINDS criteria, and were associated with novel tau-positive astrocytes (spiny astrocytes). We thus conclude that astrocytic plaques and tufts of abnormal fibers are highly characteristic structures for CBD and typical PSP, respectively. We emphasize the importance of strict differentiation between different astrocytic inclusions not only for diagnosis, but also for further studies for elucidation of their role in the disease mechanisms of CBD and PSP.
引用
收藏
页码:401 / 408
页数:7
相关论文
共 50 条
  • [31] Key emerging issues in progressive supranuclear palsy and corticobasal degeneration
    Josephs, Keith A.
    [J]. JOURNAL OF NEUROLOGY, 2015, 262 (03) : 783 - 788
  • [32] Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options
    Ruth Lamb
    Jonathan D. Rohrer
    Andrew J. Lees
    Huw R. Morris
    [J]. Current Treatment Options in Neurology, 2016, 18
  • [33] Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy
    Walter, U
    Dressler, D
    Wolters, A
    Probst, T
    Grossmann, A
    Benecke, R
    [J]. NEUROLOGY, 2004, 63 (03) : 504 - 509
  • [35] Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy
    Okuda, B
    Tachibana, H
    Kawabata, K
    Takeda, M
    Sugita, M
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2000, 14 (01): : 46 - 52
  • [36] Progressive supranuclear palsy and corticobasal degeneration: Lumping versus splitting
    Scaravilli, T
    Tolosa, E
    Ferrer, I
    [J]. MOVEMENT DISORDERS, 2005, 20 : S21 - S28
  • [37] Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
    Sharon Sha
    Craig Hou
    Indre V Viskontas
    Bruce L Miller
    [J]. Nature Clinical Practice Neurology, 2006, 2 : 658 - 665
  • [38] Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
    Sha, ron Sha
    Hou, Craig
    Viskontas, Indre V.
    Miller, Bruce L.
    [J]. NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (12): : 658 - 665
  • [39] Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration
    Ishizawa, K
    Dickson, DW
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (06): : 647 - 657
  • [40] Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy
    Borroni, Barbara
    Alberici, Antonella
    Agosti, Chiara
    Cosseddu, Maura
    Padovani, Alessandro
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2009, 21 (03) : 463 - 468